BioGeometry

BioGeometry is a digital biology company applying generative artificial intelligence to protein design for biomedicine and synthetic biology. Its GeoBiologics platform and high-throughput wet-lab validation capabilities connect design, testing, and learning in a closed-loop process intended to make protein discovery and optimization more precise and efficient.

At the center of its technology is GeoFlow V3, which the company describes as a generative AI model integrating biomolecular sequence, structure, and function. The platform supports de novo protein design, including epitope-specific antibody generation and optimization, as well as enzyme development. BioGeometry highlights applications such as improving enzyme activity, stability, and selectivity, and designing biologics for challenging drug targets.

The company aims to contribute to human health and a more sustainable planet. Its work in biomedicine supports next-generation biologics, while its synthetic biology efforts focus on bio-manufacturing with improved yields and reduced pollution. BioGeometry also reports developing GeoCell and advancing an in-house pipeline, alongside expanding automated laboratory capabilities and commercializing its technologies.